NYSE:MLSS Milestone Scientific (MLSS) Stock Price, News & Analysis $0.38 -0.01 (-3.31%) As of 01:57 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock About Milestone Scientific Stock (NYSE:MLSS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Milestone Scientific alerts:Sign Up Key Stats Today's Range$0.37▼$0.3950-Day Range$0.25▼$0.4752-Week Range$0.22▼$1.02Volume106,234 shsAverage Volume1.44 million shsMarket Capitalization$33.20 millionP/E RatioN/ADividend YieldN/APrice Target$1.00Consensus RatingBuy Company Overview Milestone Scientific, Inc., listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections. At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots. Complementing STA is the CompuFlo® Epidural System, which employs real-time pressure sensing to identify tissue planes and facilitate safer, more accurate epidural needle placement. Both systems are supported by a growing body of clinical research, patents and peer-reviewed publications that underscore their efficacy and safety. Milestone Scientific distributes its technologies through a combination of direct sales and partnerships with dental and medical distributors, serving markets across North America, Europe, Latin America and parts of Asia. The company maintains strategic relationships with dental institutions, hospitals and specialty clinics to drive adoption and training. In addition to product sales, Milestone offers continuing education programs for clinicians, ensuring that users are proficient in device operation and best practices for pain management. Founded in 1995 and headquartered in Livingston, New Jersey, Milestone Scientific was established to bridge the gap between conventional syringe techniques and modern computer-aided delivery systems. The company’s leadership team brings together experience in medical device development, regulatory affairs and commercial strategy to support global expansion and ongoing innovation. Through sustained investment in research and development, Milestone Scientific continues to advance its platform technologies and explore new applications in both dental and medical markets.AI Generated. May Contain Errors. Read More Milestone Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreMLSS MarketRank™: Milestone Scientific scored higher than 34% of companies evaluated by MarketBeat, and ranked 711th out of 858 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingMilestone Scientific has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.Upside PotentialMilestone Scientific has a consensus price target of $1.00, representing about 159.7% upside from its current price of $0.39.Amount of Analyst CoverageMilestone Scientific has received no research coverage in the past 90 days.Read more about Milestone Scientific's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Milestone Scientific is -5.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Milestone Scientific is -5.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMilestone Scientific has a P/B Ratio of 3.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for MLSS. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMilestone Scientific does not currently pay a dividend.Dividend GrowthMilestone Scientific does not have a long track record of dividend growth. News and Social Media2.0 / 5News Sentiment0.25 News SentimentMilestone Scientific has a news sentiment score of 0.25. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Milestone Scientific this week, compared to 1 article on an average week. Company Ownership0.5 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Milestone Scientific insiders have not sold or bought any company stock.Percentage Held by Insiders12.51% of the stock of Milestone Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions5.79% of the stock of Milestone Scientific is held by institutions.Read more about Milestone Scientific's insider trading history. Receive MLSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLSS Stock News HeadlinesMilestone Scientific (NYSE:MLSS) Stock Price Down 2.3% - What's Next?May 22 at 3:16 AM | americanbankingnews.comAnalysts Are Bullish on These Healthcare Stocks: Milestone Scientific (MLSS), Inhibikase Therapeutics (IKT)May 17, 2026 | theglobeandmail.comOne filing just changed the SpaceX IPO foreverSpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access. But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price.May 22 at 1:00 AM | Behind the Markets (Ad)Milestone Scientific Inc (MLSS) Q1 2026 Earnings Call Highlights: Strategic Growth Amid Global ...May 16, 2026 | finance.yahoo.comMilestone Scientific Inc. (MLSS) Q1 2026 Earnings Call TranscriptMay 14, 2026 | seekingalpha.comMilestone Scientific Reports Financial Results for First Quarter 2026May 14, 2026 | globenewswire.comMilestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference CallMay 7, 2026 | globenewswire.comMilestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical AdoptionMay 7, 2026 | globenewswire.comSee More Headlines MLSS Stock Analysis - Frequently Asked Questions How have MLSS shares performed this year? Milestone Scientific's stock was trading at $0.2730 on January 1st, 2026. Since then, MLSS stock has increased by 41.0% and is now trading at $0.3850. How were Milestone Scientific's earnings last quarter? Milestone Scientific Inc. (NYSE:MLSS) posted its earnings results on Thursday, August, 15th. The company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of ($0.01) by $0.01. The company earned $1.85 million during the quarter. Milestone Scientific had a negative trailing twelve-month return on equity of 60.26% and a negative net margin of 52.01%. How do I buy shares of Milestone Scientific? Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Milestone Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Milestone Scientific investors own include Waste Connections (WCN), DiamondRock Hospitality (DRH), The RMR Group (RMR), AUO (AUOTY), iShares Micro-Cap ETF (IWC), American Water Works (AWK) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings8/15/2024Today5/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (2w+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 2 weeks, MLSS's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNYSE:MLSS CIK855683 Webwww.milestonescientific.com Phone(973) 535-2717Fax973-535-2829Employees30Year Founded1989Price Target and Rating Average Price Target for Milestone Scientific$1.00 High Price Target$1.00 Low Price Target$1.00 Potential Upside/Downside+165.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)($0.05) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.93 million Net Margins-52.01% Pretax Margin-52.21% Return on Equity-60.26% Return on Assets-40.23% Debt Debt-to-Equity RatioN/A Current Ratio2.85 Quick Ratio1.86 Sales & Book Value Annual Sales$8.90 million Price / Sales3.73 Cash FlowN/A Price / Cash FlowN/A Book Value$0.11 per share Price / Book3.43Miscellaneous Outstanding Shares88,075,000Free Float58,614,000Market Cap$33.20 million OptionableOptionable Beta0.97 Social Links The 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NYSE:MLSS) was last updated on 5/22/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredThis stock has 30 days of quiet leftA small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...Behind the Markets | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredElon’s Biggest Launch Ever: 15x Bigger Than SpaceXThe Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked Amer...InvestorPlace | Sponsored"Computers are about to become obsolete" - George Gilder. Here’s why.George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...Eagle Publishing | SponsoredHidden on Tesla's filing: A $12 billion "super startup"Tesla's most recent SEC filing contains a single line showing $12 billion in revenue from a new venture Elon M...Banyan Hill Publishing | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
